Misleading interpretation of pharmacogenomic testing results

The October 2017 issue of the American Journal of Psychiatry a clinical case conference was published that draws attention to the serious problem of misuse of pharmacogenomic information (Rahman et al., 2017). Here is a summary of what happened: The patient was a 25-year-old man with schizophrenia who had marked positive symptoms. He had been hospitalized…